CELC logo

CELC
Celcuity Inc

1,870
Mkt Cap
$4.84B
Volume
407,742.00
52W High
$120.32
52W Low
$7.58
PE Ratio
-28.47
CELC Fundamentals
Price
$104.51
Prev Close
$104.87
Open
$105.05
50D MA
$105.42
Beta
0.98
Avg. Volume
771,786.65
EPS (Annual)
-$2.83
P/B
38.67
Rev/Employee
$0.00
$379.24
Loading...
Loading...
News
all
press releases
Has Celcuity (CELC) Outpaced Other Medical Stocks This Year?
Here is how Celcuity, Inc. (CELC) and Day One Biopharmaceuticals, Inc. (DAWN) have performed compared to their sector so far this year.
Zacks·4d ago
News Placeholder
More News
News Placeholder
Soleus Adds a Significant Number of Celcuity Shares
Key PointsSoleus increased its Celcuity stake by 629,398 shares...
Nasdaq News: Markets·4d ago
News Placeholder
Celcuity CEO Sets July 17 PDUFA for Gedatolisib, Teases VIKTORIA-1 Mutant Data at Conference
Celcuity (NASDAQ:CELC) CEO Brian Sullivan outlined the company's expected regulatory timeline and commercial preparations for gedatolisib during an appearance at the Guggenheim Healthcare Conference...
MarketBeat·5d ago
News Placeholder
Candriam S.C.A. Increases Holdings in Celcuity, Inc. $CELC
Candriam S.C.A. increased its position in Celcuity, Inc. (NASDAQ:CELC - Free Report) by 48.3% during the 3rd quarter, according to the company in its most recent disclosure with the Securities...
MarketBeat·7d ago
News Placeholder
Celcuity, Inc. $CELC Stake Boosted by New York State Common Retirement Fund
New York State Common Retirement Fund raised its holdings in shares of Celcuity, Inc. (NASDAQ:CELC - Free Report) by 68.0% in the 3rd quarter, according to the company in its most recent disclosure...
MarketBeat·8d ago
News Placeholder
Director Sells 20,000 Celcuity Shares for $2.4 Million Following 933% Share Price Jump
Key PointsDavid Dalvey sold 20,000 shares indirectly on Jan. 27, 2026 for a transaction value of ~$2.4 million, at a weighted average price of $120.03 per share...
Nasdaq News: Markets·10d ago
News Placeholder
Atle Fund Management AB Takes $1.84 Million Position in Celcuity, Inc. $CELC
Atle Fund Management AB bought a new position in shares of Celcuity, Inc. (NASDAQ:CELC - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the...
MarketBeat·16d ago
News Placeholder
Celcuity (NASDAQ:CELC) Director David Dalvey Sells 20,000 Shares
Celcuity, Inc. (NASDAQ:CELC - Get Free Report) Director David Dalvey sold 20,000 shares of the company's stock in a transaction on Tuesday, January 27th. The shares were sold at an average price of...
MarketBeat·18d ago
News Placeholder
Celcuity (NASDAQ:CELC) Director Sells $2,400,600.00 in Stock
Celcuity, Inc. (NASDAQ:CELC - Get Free Report) Director David Dalvey sold 20,000 shares of the stock in a transaction dated Tuesday, January 27th. The shares were sold at an average price of $120.03...
MarketBeat·18d ago
News Placeholder
Is Cabaletta Bio (CABA) Outperforming Other Medical Stocks This Year?
Here is how Cabaletta Bio, Inc. (CABA) and Celcuity, Inc. (CELC) have performed compared to their sector so far this year.
Zacks·21d ago
<
1
2
...
>

Latest CELC News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.